Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- NLRs and TLRs mediate elimination of pathogens
- The NOD-like receptor (NLR) family
- NLR mutations and susceptibility to diseases
- Signal transduction pathways involving NLRs
- Cell wall molecules recognized by Nod1/2
- Internalization of Nod1/2 activators
- NLR oligomerization induces downstream events
- Nod1/2 signaling pathway
- Function of Nod1 at epithelial barriers
- Nod2
- MDP internalization by macrophages
- MDP localizes to acidic vesicles in macrophages
- Crohn's disease (CD)
- Genetic variants of Nod2 associated with CD
- Recognition of MDP by CD-associated mutants
- NF-kB activation mediated by MDP requires Nod2
- MDP induced IL-8 response
- Four mechanisms for explaining CD susceptibility
- Requirements for TLR and MDP synergism
- TLR signaling is impaired by Nod2 mutations
- Nod2 mutations are associated with ileal disease
- Expression of Nod2 protein in Paneth cells
- Putative in vivo roles for Paneth cells
- Critical role for Nod2 in Listeria infection
- Reduced Paneth cell defensins in ileal CD
- Host defense: a double edged sword
- TLR tolerization
- Lack of cross-tolerization
- NF-kB, MAPK in LPS, MDP-treated macrophages
- Gene microarray analysis
- Nod1/2 are critical for responses to Listeria
- Listeria clearance from the liver
- IL6 secretion and survival in the absence of Nod1/2
- Role of Nod1/2 in tolerized macrophages
- Model for the role of Nod2 in Crohn's disease
- Caspase 1 activation
- Ipaf and TLR in response to pathogens
- Treatment of MWS patients with IL1ra
- WT and Nlrp3-/- macrophage response
- Alternative: the 'cytosolic sensing' model
- The role of pannexin-1 in inflammasome activation
- Relocalization of MDP in response to ATP
- Re-localization of MDP is regulated by pannexin-1
- Summary of caspase-1 activation model
- Acknowledgement
Topics Covered
- Signaling pathways involved in the recognition of microbes
- Nod-like receptors (NLRs)
- Signaling pathways activated by NLRs
- Microbial components sensed by NLRs
- Nod1 and Nod2 signaling pathways
- Nod2 and Crohn's disease
- Interactions between TLRs and NLRs
- The inflammasome
- NLRs and the Inflammasome
Talk Citation
Nunez, G. (2009, June 30). NOD-like receptors in innate immunity and inflammatory disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/TEUW7521.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Gabriel Nunez has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.